Literature DB >> 4420227

Posterior subcapsular cataract in nephrotic children receiving steroid therapy.

Y Kobayashi, K Akaishi, T Nishio, Y Kobayashi, Y Kimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4420227     DOI： 10.1001/archpedi.1974.02110300081010

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  7 in total

1.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

2.  Posterior subcapsular cataracts: posttransplantation in children.

Authors:  R N Fine; G Offner; W A Wilson; M R Mickey; A F Pennisi; M H Malekzadeh
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

3.  Ocular complications in children with nephrotic syndrome on long term oral steroids.

Authors:  S Gaur; M Joseph; S Nityanandam; S Subramanian; A S Koshy; A Vasudevan; K D Phadke; A Iyengar
Journal:  Indian J Pediatr       Date:  2014-02-21       Impact factor: 1.967

4.  Corticosteroid-induced cataracts in idiopathic nephrotic syndrome.

Authors:  J T Brocklebank; R B Harcourt; S R Meadow
Journal:  Arch Dis Child       Date:  1982-01       Impact factor: 3.791

5.  Cortisone cataract in children with nephrotic syndrome.

Authors:  H J Bachmann; P Schildberg; H Olbing; D Krämer; T Waubke
Journal:  Eur J Pediatr       Date:  1977-03-18       Impact factor: 3.183

6.  Cataracts in childhood leukaemia.

Authors:  A J Elliott; A Oakhill; S Goodman
Journal:  Br J Ophthalmol       Date:  1985-06       Impact factor: 4.638

7.  Prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting.

Authors:  Faith Nakubulwa; Rebecca Claire Lusobya; Anthony Batte; Bashir Ssuna; Damalie Nakanjako; Lydia Nakiyingi; Caroline Nalukenge; Francis Onen Sebabi; Ben Mulinde; Juliet Otiti-Sengeri
Journal:  BMC Ophthalmol       Date:  2021-01-22       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.